260 related articles for article (PubMed ID: 26062685)
41. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets.
Maroney SA; Haberichter SL; Friese P; Collins ML; Ferrel JP; Dale GL; Mast AE
Blood; 2007 Mar; 109(5):1931-7. PubMed ID: 17082321
[TBL] [Abstract][Full Text] [Related]
42. Differences in thromboxane A2 synthesis by megakaryocytes and platelets.
Wojenski CM; Schick PK
J Lab Clin Med; 1991 Oct; 118(4):370-6. PubMed ID: 1940580
[TBL] [Abstract][Full Text] [Related]
43. miRNAs can increase the efficiency of ex vivo platelet generation.
Emmrich S; Henke K; Hegermann J; Ochs M; Reinhardt D; Klusmann JH
Ann Hematol; 2012 Nov; 91(11):1673-84. PubMed ID: 22763947
[TBL] [Abstract][Full Text] [Related]
44. Expression of a foreign protein in human megakaryocytes and platelets by retrovirally mediated gene transfer.
Burstein SA; Dubart A; Norol F; Debili N; Friese P; Downs T; Yu X; Kincade PW; Villeval JL; Vainchenker W
Exp Hematol; 1999 Jan; 27(1):110-6. PubMed ID: 9923449
[TBL] [Abstract][Full Text] [Related]
45. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.
Fujimura H; Altar CA; Chen R; Nakamura T; Nakahashi T; Kambayashi J; Sun B; Tandon NN
Thromb Haemost; 2002 Apr; 87(4):728-34. PubMed ID: 12008958
[TBL] [Abstract][Full Text] [Related]
46. A cell-based model of thrombin generation.
Roberts HR; Hoffman M; Monroe DM
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():32-8. PubMed ID: 16673264
[TBL] [Abstract][Full Text] [Related]
47. Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass.
Shibamiya A; Tabuchi N; Chung J; Sunamori M; Koyama T
Thromb Haemost; 2004 Jul; 92(1):124-31. PubMed ID: 15213853
[TBL] [Abstract][Full Text] [Related]
48. Biosynthesis of factor V in isolated guinea pig megakaryocytes.
Chiu HC; Schick PK; Colman RW
J Clin Invest; 1985 Feb; 75(2):339-46. PubMed ID: 3973008
[TBL] [Abstract][Full Text] [Related]
49. Human platelets do not express tissue factor.
Østerud B; Olsen JO
Thromb Res; 2013 Jul; 132(1):112-5. PubMed ID: 23623171
[TBL] [Abstract][Full Text] [Related]
50. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles.
Flaumenhaft R; Dilks JR; Richardson J; Alden E; Patel-Hett SR; Battinelli E; Klement GL; Sola-Visner M; Italiano JE
Blood; 2009 Jan; 113(5):1112-21. PubMed ID: 18802008
[TBL] [Abstract][Full Text] [Related]
51. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.
Figueiredo C; Blaszczyk R
J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449
[TBL] [Abstract][Full Text] [Related]
52. Production of functional platelet-like particles by the megakaryoblastic DAMI cell line provides a model for platelet biogenesis.
Lev PR; Goette NP; Glembotsky AC; Laguens RP; Meckert PM; Salim JP; Heller PG; Pozner RG; Marta RF; Molinas FC
Platelets; 2011; 22(1):28-38. PubMed ID: 21143024
[TBL] [Abstract][Full Text] [Related]
53. Platelet-like particle formation in the human megakaryoblastic leukaemia cell lines, MEG-01 and MEG-01s.
Takeuchi K; Satoh M; Kuno H; Yoshida T; Kondo H; Takeuchi M
Br J Haematol; 1998 Feb; 100(2):436-44. PubMed ID: 9488640
[TBL] [Abstract][Full Text] [Related]
54. Platelets and phospholipids in tissue factor-initiated thrombin generation.
Butenas S; Branda RF; van't Veer C; Cawthern KM; Mann KG
Thromb Haemost; 2001 Aug; 86(2):660-7. PubMed ID: 11522019
[TBL] [Abstract][Full Text] [Related]
55. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
Petrides PE; Siegel F
Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
[TBL] [Abstract][Full Text] [Related]
56. Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4.
Matus V; Valenzuela JG; Hidalgo P; Pozo LM; Panes O; Wozniak A; Mezzano D; Pereira J; Sáez CG
PLoS One; 2017; 12(9):e0185431. PubMed ID: 28957360
[TBL] [Abstract][Full Text] [Related]
57. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins.
Villeneuve J; Block A; Le Bousse-Kerdilès MC; Lepreux S; Nurden P; Ripoche J; Nurden AT
Exp Hematol; 2009 Jul; 37(7):849-56. PubMed ID: 19410025
[TBL] [Abstract][Full Text] [Related]
58. Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa.
Lopez-Vilchez I; Escolar G; Diaz-Ricart M; Fuste B; Galan AM; White JG
Thromb Haemost; 2007 Feb; 97(2):202-11. PubMed ID: 17264948
[TBL] [Abstract][Full Text] [Related]
59. In vivo defibrination results in markedly decreased amounts of fibrinogen in rat megakaryocytes and platelets.
Handagama PJ; Shuman MA; Bainton DF
Am J Pathol; 1990 Dec; 137(6):1393-9. PubMed ID: 2260627
[TBL] [Abstract][Full Text] [Related]
60. Impact of Tissue Factor Localization on Blood Clot Structure and Resistance under Venous Shear.
Govindarajan V; Zhu S; Li R; Lu Y; Diamond SL; Reifman J; Mitrophanov AY
Biophys J; 2018 Feb; 114(4):978-991. PubMed ID: 29490257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
